New research on prenatal acetaminophen use reveals conflicting evidence about ADHD risk, leaving expectant mothers uncertain about this common pain reliever's safety.

At a Glance

• Recent studies show contradictory findings regarding the link between acetaminophen use during pregnancy and ADHD in children
• Some research suggests up to three times higher ADHD risk with prenatal acetaminophen exposure, particularly during the second trimester
• A large Swedish study of over 2 million children challenges these findings, suggesting other factors like genetics may explain the association
• Medical experts recommend pregnant women consult with healthcare providers before using any medication, including acetaminophen
• Acetaminophen remains the pain reliever of choice during pregnancy, used by 55-65% of expectant mothers

Understanding the Research Controversy

The safety of acetaminophen during pregnancy has become a subject of intense scientific debate. Used by more than half of pregnant women worldwide, this common pain reliever has long been considered the safest option for managing pain and fever during pregnancy. However, multiple cohort studies have raised questions about potential links to neurodevelopmental issues in children, particularly attention deficit hyperactivity disorder (ADHD), creating significant concern among expectant mothers and healthcare providers.

A study from Johns Hopkins Bloomberg School of Public Health found that children with higher acetaminophen levels in cord blood were approximately three times more likely to receive an ADHD or autism diagnosis later in childhood. Researchers measured acetaminophen and its metabolites in umbilical cord blood samples from nearly 1,000 births, confirming widespread use of the medication during pregnancy and suggesting possible neurodevelopmental impacts.

https://www.youtube.com/watch?v=c00t_SS5RyI

Danish and Norwegian cohort studies similarly found associations between acetaminophen use and behavioral issues. The Danish study reported higher behavioral problem scores at age 7 and increased diagnoses of hyperkinetic disorder in children whose mothers used acetaminophen during pregnancy. The Norwegian research found that extended use (28+ days) correlated with reduced motor skills, delayed walking, increased activity, and attention-seeking behaviors in children.

https://twitter.com/NeuroscienceNew/status/1777741717875085716

Challenging the Connection

Despite these concerning findings, a recently published study in JAMA offers contradictory evidence. Analyzing data from over 2 million Swedish children, researchers found that while 9% of children whose mothers took acetaminophen were diagnosed with autism, ADHD, or intellectual disabilities (compared to 7.5% whose mothers did not use the drug), the association disappeared when controlling for other factors. The study included a powerful analysis of sibling pairs where mothers used acetaminophen in one pregnancy but not the other.

This perspective suggests that previously observed associations may be explained by confounding factors rather than the medication itself. This highlights a significant limitation in many of the studies suggesting a link between acetaminophen and ADHD.

https://twitter.com/JAMA_current/status/1781638974282383393

Biological Mechanisms Under Investigation

Researchers are working to understand how acetaminophen might influence fetal development. A recent study published in Nature Mental Health found that children of mothers with acetaminophen metabolites in plasma samples had a 3.15 times higher likelihood of ADHD diagnosis. Interestingly, the association was significantly stronger in female children, who showed a 6.16 times higher likelihood compared to males, suggesting possible sex-specific effects.

Some research suggests acetaminophen exposure may affect the developing fetal brain through disruptions to immune system pathways. DNA changes related to immune function were found in placentas exposed to acetaminophen, potentially explaining the connection to neurodevelopmental outcomes

Guidance for Expectant Mothers

Despite conflicting research, medical experts emphasize that acetaminophen remains the preferred pain reliever during pregnancy. However, healthcare providers increasingly recommend a cautious approach, suggesting pregnant women consult their physicians before taking any medication, including acetaminophen.

Some researchers suggest medical societies and the FDA should update guidance on acetaminophen use as new safety data emerges. In the meantime, the consensus advice emphasizes using the lowest effective dose for the shortest duration necessary. This balanced approach acknowledges both the importance of pain management during pregnancy and the need for caution given the evolving research landscape.
​

Sources:

https://pmc.ncbi.nlm.nih.gov/articles/PMC4096264/

https://www.nbcnews.com/health/womens-health/acetaminophen-pregnancy-not-adhd-autism-risk-rcna146893

https://www.sciencedirect.com/science/article/pii/S0892036224000011

https://pubmed.ncbi.nlm.nih.gov/38592388/

https://hub.jhu.edu/2019/11/05/acetaminophen-pregnancy-autism-adhd/

https://www.foxnews.com/health/childrens-adhd-risk-linked-mothers-use-common-otc-pain-reliever

https://newsroom.uw.edu/news-releases/child-adhd-risk-linked-to-mothers-use-of-acetaminophen